-
S-Adenosylhomocysteine in Neural Differentiation Assays
2026-09-14
Use S-Adenosylhomocysteine to test whether methylation potential modifies radiation-associated neural differentiation rather than treating SAH as a nonspecific stressor. This workflow combines SAM/SAH ratio modulation with morphology, neuronal markers, and PI3K-STAT3-mGluR1 pathway analysis for a more discriminating assay.
-
Milk-Derived EV Uptake in Intestinal Stem Cell Models
2026-09-13
This study establishes porcine intestinal stem cell–based organoid models that more closely represent epithelial organization than conventional cell lines and uses them to examine milk-derived extracellular vesicle uptake. Its central finding is that uptake depends on epithelial orientation and intestinal region, while pharmacological endocytosis inhibition provides evidence that active internalization contributes to MEV entry.
-
CCK8 Workflow for Hydrogel Cancer Studies
2026-09-12
Use cck8 to connect targeted hydrogel design with quantitative cell viability measurement in breast cancer models. This practical workflow covers controls, dose–time experiments, particle interference, and interpretation of WST-8 readouts for reproducible cytotoxicity studies.
-
p-Cresyl Sulfate and Aortic Valve Calcification
2026-09-11
A 2026 study identifies p-Cresyl sulfate as an active enhancer of calcification in aortic valvular interstitial cells, rather than only a retained marker of kidney dysfunction. Its porcine-cell and rat CKD models connect PCS exposure with HIF-1α activation, klotho loss, and NF-κB/RUNX2 signaling, while testing klotho supplementation and SIRT1 activation as countermeasures.
-
GSK126: Mapping EZH2 Control of Immune Signaling
2026-09-11
Explore how GSK126, a selective EZH2 inhibitor, can connect H3K27me3 remodeling with chemokine expression and immune-cell recruitment. This article translates a decidual epigenetics study into a rigorous assay framework relevant to cancer epigenetics research and oncology drug development.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-10
Build a dual-readout workflow that separates mRNA uptake from productive translation using Cy5 fluorescence and Firefly luciferase bioluminescence. This guide combines practical transfection optimization with carrier-tropism insights from a lung-targeting mRNA study.
-
Tunicamycin for ER Stress Research
2026-09-10
Tunicamycin is a practical N-glycosylation inhibitor for building controlled ER-stress models, from RAW264.7 macrophage inflammation assays to glioblastoma resistance studies. This guide translates its mechanism into dose-finding, multi-readout workflows and troubleshooting strategies centered on GRP78, UPR signaling, COX-2, iNOS and FKBP9 biology.
-
AO/PI Staining Solution in Kidney Cell Models
2026-09-09
Learn how AO/PI Staining Solution supports fluorescence-based cell counting in diabetic nephropathy models. This guide connects membrane-integrity measurements with the inflammatory and apoptotic mechanisms reported for phillygenin, while clarifying what the assay can and cannot prove.
-
RNA Pol II Inhibition and the PDAR Mechanism
2026-09-09
Harper and colleagues show that RNA Pol II inhibition kills cells through an active apoptotic pathway triggered by depletion of hypophosphorylated Rpb1, rather than through transcriptional failure alone. The study defines the Pol II degradation-dependent apoptotic response and uses functional genomics to connect nuclear Pol II loss with mitochondrial cell death, providing a framework for interpreting the activity of transcription-targeting therapies.
-
TRIM66 and Monogenic Olfactory Receptor Expression
2026-09-08
The reference study identifies TRIM66 as an epigenetic repressor that helps convert initially polygenic olfactory receptor expression into the mature one-neuron–one-receptor state. Genetic loss of Trim66 disrupts receptor selection, neural activity, and innate olfactory behavior, linking enhancer repression to sensory-circuit function.
-
N2703 in Cardiac Signaling Assays
2026-09-08
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can support hypothesis-driven cardiac signaling assays without overstating its mechanism. This article translates the adipose-neural arrhythmia model into practical probe-selection, control, and interpretation strategies.
-
Mechanical Stress and Cytoskeleton-Dependent Autophagy
2026-09-07
The reference study provides direct evidence that cytoskeletal microfilaments are central to autophagy triggered by cellular compression, while microtubules contribute in an auxiliary manner. Its perturbation-based design links cytoskeletal organization with mechanotransduction and offers a framework for separating force sensing from downstream autophagy responses.
-
Fluoxetine HCl Workflows for Neuroscience Research
2026-09-07
Fluoxetine HCl enables concentration-aware studies of serotonin transport, 5-HT2C signaling, neuroplasticity, and reward behavior. This workflow connects molecular assays with developmental SSRI findings while showing how to separate motivation deficits from changes in reward liking or learning.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-05
CAY10499 provides a quantitative way to perturb HSL, MGL, and related lipid signaling in enzyme assays, monocyte-to-macrophage models, and lipid-flux studies. Its strongest value is as an orthogonal lipid-metabolism probe for testing how EV-driven metabolic reprogramming relates to tumor-associated macrophage biology, not as a substitute for direct ACLY inhibition.
-
Coelenterazine for ROS Reporter Assays
2026-09-04
Coelenterazine connects coelenterate luciferase reporters with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide explains solvent handling, kinetic workflows, AVP-axis applications, cancer-associated ROS imaging, and controls that separate reporter activity from oxidative chemistry.